Mardi Dier

Insider Reports History

Location
Agoura Hills, CA
Signature
/s/ Christian Kuhlen, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mardi Dier:

Company Role Class Num Shares Value Price $ Report Date Ownership
MADRIGAL PHARMACEUTICALS, INC. EVP and CFO Common Stock 10,440 $6,224,171 $596.18 02 Dec 2025 Direct
Ultragenyx Pharmaceutical Inc. CFO & Executive Vice President Common Stock 66,695 $1,400,595 $21.00 14 Oct 2022 Direct
Adamas Pharmaceuticals Inc Director Common Stock 10,000 $51,585 $5.16 02 Jun 2021 Direct
ACELYRIN, Inc. CFO and CBO Common Stock 5,556 $41,153 $7.41 09 May 2023 Direct
ACELYRIN, Inc. CFO and CBO Common Stock 875 $6,481 $7.41 09 May 2023 Indirect
ACELYRIN, Inc. CFO and CBO Employee Stock Option (right to buy) 85,226 09 May 2023 Direct
Oric Pharmaceuticals, Inc. Director Stock Option (right to buy) 40,000 02 Jan 2026 Direct
Prelude Therapeutics Inc Director Director Stock Option (Right to Buy) 38,000 12 Jun 2025 Direct
Ultragenyx Pharmaceutical Inc. CFO & Executive Vice President Stock Option (Right to Buy) 24,900 01 Mar 2022 Direct
Adamas Pharmaceuticals Inc Director Stock Option (Right to Buy) 10,000 02 Jun 2021 Direct
MADRIGAL PHARMACEUTICALS, INC. EVP and CFO Stock Option (Right to Buy) 9,180 02 Dec 2025 Direct

Insider Reports Filed by Mardi Dier

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ORIC Oric Pharmaceuticals, Inc. 02 Jan 2026 1 $0 4 Director 06 Jan 2026, 16:44
MDGL MADRIGAL PHARMACEUTICALS, INC. 02 Dec 2025 17 -$1,363,364 4 EVP and CFO 03 Dec 2025, 17:59
PRLD Prelude Therapeutics Inc 12 Jun 2025 1 $0 4 Director 13 Jun 2025, 16:15
MDGL MADRIGAL PHARMACEUTICALS, INC. 10 Mar 2025 1 -$83,344 4 SVP and CFO 12 Mar 2025, 16:32
MDGL MADRIGAL PHARMACEUTICALS, INC. 05 Mar 2025 2 $0 4 SVP and CFO 07 Mar 2025, 17:43
MDGL MADRIGAL PHARMACEUTICALS, INC. 03 Mar 2025 2 -$637,248 4 SVP and CFO 05 Mar 2025, 16:31
ORIC Oric Pharmaceuticals, Inc. 02 Jan 2025 1 $0 4 Director 06 Jan 2025, 16:43
PRLD Prelude Therapeutics Inc 14 Jun 2024 1 $0 4 Director 18 Jun 2024, 16:13
ORIC Oric Pharmaceuticals, Inc. 12 Jun 2024 1 $0 4 Director 14 Jun 2024, 16:22
MDGL MADRIGAL PHARMACEUTICALS, INC. 11 Mar 2024 0 $0 3 SVP and CFO 21 Mar 2024, 16:30
PRLD Prelude Therapeutics Inc 16 Jun 2023 1 $0 4 Director 21 Jun 2023, 16:13
ORIC Oric Pharmaceuticals, Inc. 14 Jun 2023 1 $0 4 Director 15 Jun 2023, 16:52
SLRN ACELYRIN, Inc. 09 May 2023 7 +$131,508 4 CFO and CBO 11 May 2023, 20:51
SLRN ACELYRIN, Inc. 04 May 2023 1 $0 4 CFO and CBO 04 May 2023, 19:59
SLRN ACELYRIN, Inc. 04 May 2023 0 $0 3 CFO and CBO 04 May 2023, 18:45
RARE Ultragenyx Pharmaceutical Inc. 14 Oct 2022 1 -$65,421 4 CFO & Executive Vice President 17 Oct 2022, 18:49
RARE Ultragenyx Pharmaceutical Inc. 12 Oct 2022 1 -$133,158 4 CFO & Executive Vice President 14 Oct 2022, 12:58
RARE Ultragenyx Pharmaceutical Inc. 16 Sep 2022 1 $0 4 CFO & Executive Vice President 19 Sep 2022, 21:39
PRLD Prelude Therapeutics Inc 17 Jun 2022 1 $0 4 Director 22 Jun 2022, 16:13
ORIC Oric Pharmaceuticals, Inc. 17 Jun 2022 1 $0 4 Director 17 Jun 2022, 20:19
RARE Ultragenyx Pharmaceutical Inc. 01 Mar 2022 4 -$62,686 4 CFO & Executive Vice President 03 Mar 2022, 17:12
RARE Ultragenyx Pharmaceutical Inc. 12 Oct 2021 2 -$552,524 4 CFO & Executive Vice President 14 Oct 2021, 18:33
PRLD Prelude Therapeutics Inc 18 Jun 2021 1 $0 4 Director 22 Jun 2021, 17:40
ORIC Oric Pharmaceuticals, Inc. 16 Jun 2021 1 $0 4 Director 17 Jun 2021, 19:42
ADMS Adamas Pharmaceuticals Inc 02 Jun 2021 2 $0 4 Director 04 Jun 2021, 16:13